EXTENSIVE INTERDIALYTIC WEIGHT GAIN

This adverse event was reported 5 times

These drugs are most commonly taken by patients reporting EXTENSIVE INTERDIALYTIC WEIGHT GAIN:

# Drug Count
0 ATAZANAVIR 1
1 CINACALCET 1
2 ETELCALCETIDE 1
3 FUROSEMIDE 1
4 GEMFIBROZIL 1
5 METOPROLOL 1
6 METOPROLOL TARTRATE 1
7 METOPROLOL TARTRATE INJECTION 1
8 PARICALCITOL 1
9 RALTEGRAVIR 1
See all common drugs associated with EXTENSIVE INTERDIALYTIC WEIGHT GAIN

EXTENSIVE INTERDIALYTIC WEIGHT GAIN is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 SODIUM THIOSULFATE 1 0.0018
1 ETELCALCETIDE 1 0.0003
2 RALTEGRAVIR 1 0.0002
3 GEMFIBROZIL 1 0.0001
4 PARICALCITOL 1 0.0001
5 ATAZANAVIR 1 0.0001
6 METOPROLOL TARTRATE 1 0.0000
7 FUROSEMIDE 1 0.0000
See all drugs enriched for association with EXTENSIVE INTERDIALYTIC WEIGHT GAIN

These drug classes are most commonly taken by patients reporting EXTENSIVE INTERDIALYTIC WEIGHT GAIN:

# Drug class Count
0 Loop Diuretic [EPC] 1
1 Peroxisome Proliferator Receptor alpha Agonist [EPC] 1
2 Vitamin D Analog [EPC] 1
3 Vitamin D2 Analog [EPC] 1
See all common drug classes associated with EXTENSIVE INTERDIALYTIC WEIGHT GAIN

EXTENSIVE INTERDIALYTIC WEIGHT GAIN is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Vitamin D2 Analog [EPC] 1 0.0001
1 Vitamin D Analog [EPC] 1 0.0001
2 Peroxisome Proliferator Receptor alpha Agonist [EPC] 1 0.0000
3 Loop Diuretic [EPC] 1 0.0000
See all drug classes enriched for association with EXTENSIVE INTERDIALYTIC WEIGHT GAIN